TCMBANKGE000106 |
SCN10A |
FEPS2; Nav1.8; PN3; SNS; hPN3 |
sodium voltage-gated channel alpha subunit 10 |
TCMBANKGE000309 |
SCN5A |
CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1 |
sodium voltage-gated channel alpha subunit 5 |
TCMBANKGE000425 |
DRD1 |
DADR; DRD1A |
dopamine receptor D1 |
TCMBANKGE000633 |
ADRB2 |
ADRB2R; ADRBR; B2AR; BAR; BETA2AR |
adrenoceptor beta 2 |
TCMBANKGE000813 |
DPP4 |
ADABP; ADCP2; CD26; DPPIV; TP103 |
dipeptidyl peptidase 4 |
TCMBANKGE000869 |
DRD2 |
D2DR; D2R |
dopamine receptor D2 |
TCMBANKGE001194 |
ADRA2A |
ADRA2; ADRA2R; ADRAR; ALPHA2AAR; ZNF32 |
adrenoceptor alpha 2A |
TCMBANKGE001506 |
ADRA1B |
ADRA1; ALPHA1BAR |
adrenoceptor alpha 1B |
TCMBANKGE001943 |
ADRA1D |
ADRA1; ADRA1A; ADRA1R; ALPHA1; DAR; dJ779E11.2 |
adrenoceptor alpha 1D |
TCMBANKGE003157 |
CHRM2 |
HM2 |
cholinergic receptor muscarinic 2 |
TCMBANKGE003625 |
SLC6A4 |
5-HTT; 5-HTTLPR; 5HTT; HTT; OCD1; SERT; SERT1; hSERT |
solute carrier family 6 member 4 |
TCMBANKGE005535 |
CHRM1 |
HM1; M1; M1R |
cholinergic receptor muscarinic 1 |
TCMBANKGE006943 |
CHRM3 |
EGBRS; HM3; PBS |
cholinergic receptor muscarinic 3 |
TCMBANKGE008056 |
ADRA2C |
ADRA2L2; ADRA2RL2; ADRARL2; ALPHA2CAR |
adrenoceptor alpha 2C |
TCMBANKGE008124 |
ADRA2B |
ADRA2L1; ADRA2RL1; ADRARL1; ALPHA2BAR; FAME2; alpha-2BAR |
adrenoceptor alpha 2B |
TCMBANKGE008702 |
OPRM1 |
LMOR; M-OR-1; MOP; MOR; MOR1; OPRM |
opioid receptor mu 1 |
TCMBANKGE009256 |
SLC6A2 |
NAT1; NET; NET1; SLC6A5 |
solute carrier family 6 member 2 |
TCMBANKGE009455 |
CHRM5 |
HM5 |
cholinergic receptor muscarinic 5 |
TCMBANKGE011923 |
CHRM4 |
HM4; M4R |
cholinergic receptor muscarinic 4 |
TCMBANKGE012155 |
SLC6A3 |
DAT; DAT1; PKDYS; PKDYS1 |
solute carrier family 6 member 3 |
TCMBANKGE014423 |
ADRA1A |
ADRA1C; ADRA1L1; ALPHA1AAR |
adrenoceptor alpha 1A |
TCMBANKGE014625 |
OPRD1 |
DOP; DOR; DOR1; OPRD |
opioid receptor delta 1 |
TCMBANKGE014790 |
ADRB1 |
ADRB1R; B1AR; BETA1AR; FNSS2; RHR |
adrenoceptor beta 1 |